Featured

Top 100 Global Innovators for 2023 revealed [Report]

Ed White

Principal Analyst and VP

arrow_forward Read more
Biopharma
The Drugs to Watch in 2023
arrow_forward Read more
Academia and Government
Highly Cited Researchers 2022: Using deeper qualitative analysis to help spot research misconduct
arrow_forward Read more
Life Sciences and Healthcare
November 2, 2016

Need to Make Changes to Your Clinical Trial? It’ll Cost Money and Time
Life Sciences and Healthcare
October 26, 2016

Understanding the alphabet soup of programmatic advertising for pharma marketers
Life Sciences and Healthcare
September 28, 2016

Educating patients about presumptive financial assistance eligibility
Life Sciences and Healthcare
August 9, 2016

Opdivo falls short in the first-line CheckMate-026 NSCLC trial – what will the repercussions be on its commercial prospects?
Life Sciences and Healthcare
June 29, 2016

The What and Why of Budget Impact Models
Life Sciences and Healthcare
June 15, 2016

Paying for Performance: EFPIA’s Catch-22 for European Drug Pricing
Life Sciences and Healthcare
May 31, 2016

Russia: Capricious or Compulsory Licensing?
Life Sciences and Healthcare
May 24, 2016

Are Narrow Networks the key to telemedicine growth?
Life Sciences and Healthcare
May 17, 2016

Oil and Healthcare: Oil Prices Create Havoc in the Land of Soccer and Samba
Life Sciences and Healthcare
May 13, 2016

More exchanges with a lone insurer on tap for 2017
Life Sciences and Healthcare
May 13, 2016

Interventional Oncology – here come the big guns
Life Sciences and Healthcare
May 12, 2016

Digital health news update: Merger mania; advertising’s existential dillema
Life Sciences and Healthcare
February 10, 2016

Latin America scrambles to contain Zika virus
Life Sciences and Healthcare
October 22, 2015

War on Cancer: A Unified Battle in the 21st Century
Life Sciences and Healthcare
October 3, 2015

The Decision Resources Group Companies Are Now DRG